跳至主要内容
临床试验/NCT02996149
NCT02996149终止不适用

Endoscopic Lung Volume Reduction Coil Treatment in Patients With Chronic Hypercapnic Respiratory Failure

Universitätsklinikum Hamburg-Eppendorf1 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2016年11月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
1
试验地点
1
主要终点
Changes in PaCO2

研究概览

简要总结

Endoscopic lung volume reduction coil treatment is a treatment option for selected patients with severe emphysema. In the advanced stages, emphysema may lead to chronic hypercapnic respiratory failure. In this observational study the safety and efficacy of endoscopic lung volume reduction coil treatment in patients with chronic hypercapnic respiratory failure is evaluated.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with emphysema (chronic obstructive pulmonary disease with forced expired volume in one second (FEV1) < 50% predicted and residual volume (RV) ≥ 200% predicted) in whom endoscopic lung volume reduction coil treatment is performed
  • Chronic hypercapnic respiratory failure (PaCO2 ≥ 50 mmHg)
  • Informed consent

排除标准

  • Therapeutic anticoagulation
  • Anti-platelet therapy exceeding the use of acetylsalicylic acid
  • Severe pulmonary hypertension

结局指标

主要结局

Changes in PaCO2

时间窗: 3 months after endoscopic lung volume reduction (ELVR)

次要结局

  • Changes in PaCO2(6 and 12 months after ELVR)
  • Changes in FEV1(3, 6 and 12 months after ELVR)
  • Changes in vital capacity(3, 6 and 12 months after ELVR)
  • Changes in residual volume(3, 6 and 12 months after ELVR)
  • Changes in 6-minute walk distance(3, 6 and 12 months after ELVR)
  • Changes in quality of life (St. George's Respiratory Questionnaire, SGRQ)(3, 6 and 12 months after ELVR)
  • Changes in BMI(3, 6 and 12 months after ELVR)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Hans Klose

Dr.

Universitätsklinikum Hamburg-Eppendorf

研究点 (1)

Loading locations...

相似试验